Breast cancer mortality reduction
|
Relative risk reduction
|
Absolute risk reduction
|
Survival time from diagnosis
|
Number needed to screen
|
Carcinoma in situ, as positive
|
Less mastectomies/more tumourectomies
|
Total mortality reduction
|
Other
|
Harms
|
Overdiagnosis and overtreatment
|
Recall rate:
|
1. Per screen
|
2. Cumulative
|
More mastectomies/more tumourectomies
|
Increased biopsy rate
|
Risks associated with additional radiotherapy
|
Psychological effects related to false positives
|
Carcinoma in situ, as negative
|
Pain at mammography
|
Other
|